https://pharmoniq.com/news/weight-loss-drugs-drive-pharma-rd-returns-growth PharmoniQ en 2026-05-05T14:10:49.170Z Weight Loss Drugs Drive Third Consecutive Year of R&D Growth GLP-1, obesity, R&D, pharmaceutical-industry, drug-development https://pharmoniq.com/news/fatal-vitamin-d-overdose-supplement-stacking-warning PharmoniQ en 2026-05-05T08:47:01.944Z Fatal Vitamin D Overdose Prompts Urgent Warning on Supplement Stacking vitamin-d, supplement-safety, overdose, pharmacist-warning, supplement-stacking https://pharmoniq.com/news/fda-proposes-excluding-semaglutide-tirzepatide-from-compounding PharmoniQ en 2026-05-04T14:10:49.947Z FDA Proposes Ban on Compounded Weight-Loss Drug Alternatives FDA, semaglutide, tirzepatide, compounding pharmacy, GLP-1 medications